Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DULAGLUTIDE
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
- A Study of IBI362 in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
- Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D
- A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
- Degludec Glargine U300 Hospital Study
- The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.
- A Study of IBI362 in Chinese Patients With Type 2 Diabetes
- Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
- GLP-1 RAs in Patients With Polycystic Ovarian Syndrome (PCOS)
- A Study of LY3437943 in Participants With Type 2 Diabetes
- Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
- A Study of LY3493269 in Participants With Type 2 Diabetes
- Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
- A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes
- A Study of Dulaglutide in Healthy Participants
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
- Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
- A Study of LY3298176 in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes
- Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
- A Study of Dulaglutide in Chinese Participants
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
- A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- A Study in Participants With Type 2 Diabetes Mellitus
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
Clinical trials list
click for details